Hypoglycaemic treatment in type 2 diabetic patients after myocardial infarction

被引：0

作者：

Szymborska-Kajanek, Aleksandra ^{[1
]}

Strojek, Krzysztof ^{[1
]}

机构：

[1] Med Univ Silesia, Dept Internal Dis Diabetol & Nephrol, Zabrze, Poland

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2006年 / 74卷

关键词：

type; 2; diabetes; DIGAMI study; MI; hypoglycaemic therapy;

D O I：

10.1016/j.diabres.2006.06.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 2 diabetic (T2D) patients are particularly prone to macrovascular complications. Coronary heart disease is two to four times more frequent in T2D patients compared with non-diabetic individuals. Patients with diabetes mellitus who underwent acute MI have unfavourable prognosis. Diabetes and Insulin-Glucose Infusion in Acute MI study (DIGAMI) has shown that metabolic control by means of insulin-glucose i.v. infusion in the acute phase of MI followed by long-term intensive insulin therapy improves prognosis in the T2D patients. The DIGAMI-2 study did not confirm conclusions of DIGAMI 1 study. The authors of this article comment on the results of DIGAMI 2 and attempt to answer how T2D patients should be treated after MI. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

引用

页码：S30 / S32

页数：3

共 12 条

[1] Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].

Adams, RJ ;

Antman, EM ;

Kavey, REW .

CIRCULATION, 2004, 110 (16) :2512-2516

[2]

[Anonymous], 1989, DIABETES CARE, V12, P573

[3] Acute hyperglycaemia: a 'new' risk factor during myocardial infarction [J].

Ceriello, A .

EUROPEAN HEART JOURNAL, 2005, 26 (04) :328-331

[4] Insulin resistance implications for type II diabetes mellitus and coronary heart disease [J].

Haffner, SM ;

Miettinen, H .

AMERICAN JOURNAL OF MEDICINE, 1997, 103 (02) :152-162

[5] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].

Haffner, SM ;

Lehto, S ;

Rönnemaa, T ;

Pyörälä, K ;

Laakso, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234

[6] MORTALITY AMONG DIABETICS IN A NATIONAL SAMPLE [J].

KLEINMAN, JC ;

DONAHUE, RP ;

HARRIS, MI ;

FINUCANE, FF ;

MADANS, JH ;

BROCK, DB .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 128 (02) :389-401

[7] Mortality prediction in diabetic patients with myocardial infarction: Experiences from the DIGAMI study [J].

Malmberg, K ;

Ryden, L ;

Hamsten, A ;

Herlitz, J ;

Waldenstrom, A ;

Wedel, H .

CARDIOVASCULAR RESEARCH, 1997, 34 (01) :248-253

[8] Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus [J].

Malmberg, K .

BRITISH MEDICAL JOURNAL, 1997, 314 (7093) :1512-1515

[9] RANDOMIZED TRIAL OF INSULIN-GLUCOSE INFUSION FOLLOWED BY SUBCUTANEOUS INSULIN-TREATMENT IN DIABETIC-PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION (DIGAMI STUDY) - EFFECTS ON MORTALITY AT 1 YEAR [J].

MALMBERG, K ;

RYDEN, L ;

EFENDIC, S ;

HERLITZ, J ;

NICOL, P ;

WALDENSTROM, A ;

WEDEL, H ;

WELIN, L .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (01) :57-65

[10]

MALMBERG K, 2005, EUR HEART J, V26, P1

← 1 2 →